Recent Posts on This Topic | See All >
[Source: The Arizona Republic] - An experimental drug that prods the body's immune system to attack advanced skin cancer has extended life for some patients suffering from the deadliest form of the disease.
If approved by the Food and Drug Administration, ipilimumab may give doctors another tool to fight melanoma that has spread beyond the skin to other parts of the body.
Bristol-Myers Squibb is expected to file for FDA approval later this year to market the drug, but it's unclear whether or when the experimental drug may become more widely available.
For more information: Experimental drug shows promise fighting skin cancer
“Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade. Also, discover The State of Bioscience.